These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 12475634
21. Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis. Zijlstra EE, el-Hassan AM, Ismael A. Am J Trop Med Hyg; 1995 Apr; 52(4):299-305. PubMed ID: 7741164 [Abstract] [Full Text] [Related]
23. An epidemiological study of visceral leishmaniasis in North East Ethiopia using serological and leishmanin skin tests. Tadese D, Hailu A, Bekele F, Belay S. PLoS One; 2019 Feb; 14(12):e0225083. PubMed ID: 31881021 [Abstract] [Full Text] [Related]
24. Applicability of direct agglutination test (DAT) at a rural health setting in Bangladesh and feasibility of local antigen production. Chowdhury MS, al Masum A, al Karim E, Semiáo-Santos S, Rahman KM, Ar-Rashid H, el Harith A. Arch Inst Pasteur Tunis; 1993 Feb; 70(3-4):333-44. PubMed ID: 7802488 [Abstract] [Full Text] [Related]
27. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors. Schenkel K, Rijal S, Koirala S, Koirala S, Vanlerberghe V, Van der Stuyft P, Gramiccia M, Boelaert M. Trop Med Int Health; 2006 Dec; 11(12):1792-9. PubMed ID: 17176343 [Abstract] [Full Text] [Related]
29. Factors affecting variations in exposure to infections by Leishmania donovani in eastern Sudan. Elnaiem DE, Mukhawi AM, Hassan MM, Osman ME, Osman OF, Abdeen MS, Abdel Raheems MA. East Mediterr Health J; 2003 Jul; 9(4):827-36. PubMed ID: 15748079 [Abstract] [Full Text] [Related]
31. Post-kala-azar dermal leishmaniasis--an overview. Ganguly S, Das NK, Barbhuiya JN, Chatterjee M. Int J Dermatol; 2010 Aug; 49(8):921-31. PubMed ID: 21128917 [Abstract] [Full Text] [Related]
32. Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar. Pampiglione S, Manson-Bahr PE, La Placa M, Borgatti MA, Musumeci S. Trans R Soc Trop Med Hyg; 1975 Aug; 69(1):60-8. PubMed ID: 1145719 [Abstract] [Full Text] [Related]
33. Kala-azar in Darfur: Evidence for indigenous transmission in Al-Malha Locality, North Darfur, western Sudan. Mohammed MA, Khalid NM, Aboud MA. Parasit Vectors; 2018 Mar 06; 11(1):149. PubMed ID: 29510744 [Abstract] [Full Text] [Related]
34. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India. Singh RP, Picado A, Alam S, Hasker E, Singh SP, Ostyn B, Chappuis F, Sundar S, Boelaert M. Trop Med Int Health; 2012 Nov 06; 17(11):1345-8. PubMed ID: 22882665 [Abstract] [Full Text] [Related]
35. Kala-azar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessment. Alvar J, Bashaye S, Argaw D, Cruz I, Aparicio P, Kassa A, Orfanos G, Parreño F, Babaniyi O, Gudeta N, Cañavate C, Bern C. Am J Trop Med Hyg; 2007 Aug 06; 77(2):275-82. PubMed ID: 17690399 [Abstract] [Full Text] [Related]
37. Leishmanin test survey in an endemic village of Indian kala-azar near Calcutta. Nandy A, Neogy AB, Chowdhury AB. Ann Trop Med Parasitol; 1987 Dec 06; 81(6):693-9. PubMed ID: 3503646 [Abstract] [Full Text] [Related]
39. Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL). Musa AM, Khalil EA, Mahgoub FA, Hamad S, Elkadaru AM, El Hassan AM. Ann Trop Med Parasitol; 2005 Sep 06; 99(6):563-9. PubMed ID: 16156969 [Abstract] [Full Text] [Related]